Pharmaceuticals

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes

Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with insomnia

When insomnia took hold of this journalist, she relied on her science reporting to find a medication that (mostly) worked

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?

Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority of people who use these drugs quit after just two years

Could gene editing produce a tasty citrus fruit that doesn’t interfere with prescription drugs?

Pandemic relaxation of buprenorphine-prescribing restrictions must continue to keep saving lives amid a U.S. overdose epidemic

Prominent vaccine skeptic RFK, Jr., is a proven menace to public health. But with a bird flu outbreak looming, he is poised to take a perch atop the federal public health enterprise

Antimicrobial resistance could claim 39 million lives by 2050, yet the pipeline for new antibiotics is drying up. U.S. policymakers can help fix it

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects